Issue 27, 2021

Advances of smart nano-drug delivery systems in osteosarcoma treatment

Abstract

Nanotechnology has recently become popular due to its potential for biomedical applications, especially for cancer treatment. Nanotechnology, featuring responsiveness to stimuli and stable drug release, has been widely used for the delivery of chemotherapeutic drugs, which are commonly used in the treatment of osteosarcoma. Smart stimuli-responsive nanotechnology is expected to improve the treatment of osteosarcoma. Herein, we focus on the latest research on nanomaterials in treating osteosarcoma that respond to internal and external stimuli. We also discuss nanocarriers with targeting ligands and the use of smart nanotechnology to partially reverse the multidrug resistance of osteosarcoma.

Graphical abstract: Advances of smart nano-drug delivery systems in osteosarcoma treatment

Article information

Article type
Review Article
Submitted
16 Mar 2021
Accepted
11 Jun 2021
First published
17 Jun 2021

J. Mater. Chem. B, 2021,9, 5439-5450

Advances of smart nano-drug delivery systems in osteosarcoma treatment

Y. Liu, Q. Li, Q. Bai and W. Jiang, J. Mater. Chem. B, 2021, 9, 5439 DOI: 10.1039/D1TB00566A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements